HPV Vaccine
The HPV vaccine is a preventive vaccine that provides immunity against the human papillomavirus (HPV), helping to prevent the development of both genital warts and HPV-related cervical, vaginal, vulvar, and anal cancers. HPV is one of the most commonly transmitted viruses through sexual contact and is the leading cause of cervical cancer in women. The vaccine provides significant protection for public health by preventing the transmission and spread of the virus in both women and men. The HPV vaccine reaches its highest efficacy when administered before the onset of sexual activity, but it provides a certain level of protection at any age. 489
What is the HPV Vaccine?
The HPV vaccine is a biological preparation that contains harmless particles of the human papillomavirus, introducing the virus to the immune system and providing protection against future infections. This vaccine does not contain live virus; therefore, it does not cause infection. The vaccines currently in use — Gardasil 4, Gardasil 9, and Cervarix — provide protection against the most common disease-causing types of HPV. Gardasil 9, in particular, protects against nine different types of HPV, including types that cause warts (6, 11) and those associated with cancer (16, 18, 31, 33, 45, 52, 58). 338
How is the HPV Vaccine Administered?
The HPV vaccine is administered intramuscularly (usually in the upper arm or hip area). It is given in two doses for individuals under 15 years of age and in three doses for those over 15. The two-dose schedule uses intervals of 0 and 6 months; the three-dose schedule uses intervals of 0, 2, and 6 months. Daily life can be resumed immediately after vaccination. The most common side effects are mild pain, redness, or a feeling of fever at the injection site, which disappear shortly. The type of vaccine to be administered is determined based on age and health status. 979
HPV and Cancer Prevention
The HPV vaccine is of great importance, especially in preventing the development of cervical cancer. Approximately 99% of cervical cancers are due to HPV infection. The vaccine prevents the virus from integrating into cell DNA by developing immunity against high-risk HPV types. This significantly reduces the incidence of cervical, vaginal, vulvar, and anal cancers, as well as HPV-related genital warts. 9ec
Duration of Protection of the HPV Vaccine
Clinical studies have shown that the protection of the HPV vaccine lasts at least 10-15 years. Currently, there is no requirement for additional doses (booster). However, in individuals with diseases affecting the immune system, the dose plan may be adjusted based on the doctor’s recommendation. The vaccine does not treat existing HPV infections; however, it prevents infection with new types. Therefore, early administration provides the most effective protection. 4a1
Who Should Receive the HPV Vaccine?
The vaccine is recommended for both girls and boys.
– **For girls:** Provides ideal protection between the ages of 9-26.
– **For boys:** Recommended between the ages of 9-21, but benefits continue at older ages.
The protection rate is highest in individuals who have not started sexual activity, but those with active sexual lives can also benefit from the vaccine. Even in the post-menopausal period, if there is a risk of exposure to HPV, the vaccine can be administered. 90d
Side Effects of the HPV Vaccine
The HPV vaccine is generally safe and well-tolerated. The most common side effects are pain, mild redness at the injection site, headache, or fatigue. In rare cases, allergic reactions have been reported. Sitting for a few minutes after vaccination reduces the risk of temporary dizziness or fainting. It should be administered with a doctor’s evaluation in individuals with severe allergies. 33f
HPV Vaccine and Pregnancy
The HPV vaccine is not recommended during pregnancy; however, no adverse effects have been reported in women who unknowingly became pregnant after vaccination. It can be safely administered during breastfeeding. It is recommended to complete the vaccine series in women planning pregnancy. 930
Follow-up After the HPV Vaccine
Although the vaccine provides high protection against HPV infection, regular gynecological examinations and Pap-smear tests should continue. This is because the vaccine does not protect against all HPV types. Regular follow-up allows for early detection and treatment of possible cellular changes. 97a
| Feature | Description |
|---|---|
| Vaccine Types | Gardasil 4, Gardasil 9, Cervarix |
| Administration Schedule | 2 doses (0-6 months) or 3 doses (0-2-6 months) |
| Duration of Protection | 10-15 years (no additional dose required) |
| Protection Area | Genital warts and HPV-related cancers |
| Side Effects | Mild pain, redness, fatigue |
HPV Vaccine Prices
HPV vaccine prices vary depending on the type of vaccine used (Gardasil 9, Gardasil 4, or Cervarix), the number of doses, and the health center where it is administered. In our clinic, personal planning is made based on the patient’s age, health status, and vaccination schedule. For current price information, please contact our clinic. 4de
The HPV vaccine is a revolutionary preventive measure in women’s health. Vaccination at an early age not only provides individual protection but also significantly reduces the incidence of HPV-related diseases in the community. 337
Frequently Asked Questions About the HPV Vaccine
Question: Does the HPV vaccine treat existing infections?
No, the HPV vaccine does not treat existing infections; however, it prevents transmission with other types of the virus. 4a1
Question: Who should not receive the HPV vaccine?
It is not recommended for those with a history of severe allergic reactions or those who are pregnant. It can be safely administered during breastfeeding. 97a
Question: Should the HPV vaccine be administered to males?
Yes, because males can be carriers of the infection and also have a risk of developing warts and cancer related to HPV. 9ec
Question: Is testing required after vaccination?
HPV testing before vaccination is not mandatory; however, regular smear and HPV tests support the protection process. 705
